International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Beyond Antidepressants: Exploring Biochemical Pathways for Next-Generation Postpartum Depression Therapies

Abidemi Omolayo Owokoya

Independent Researcher, Atlanta, Georgia, United States

Article Information

Volume / Issue6 / 4 (October-December 2025)
Pages77-92
AccessOpen Access

Publication Timeline

  • Received05 September 2025
  • Accepted06 October 2025
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Postpartum depression (PPD) remains a significant global health concern, affecting approximately one in seven mothers, with profound consequences for maternal well-being, infant development, and family stability. Current therapeutic approaches, predominantly antidepressant medications and psychotherapy, have demonstrated only partial efficacy and often face challenges related to delayed onset of action, limited accessibility, and patient reluctance due to safety concerns during breastfeeding. These limitations underscore the urgent need for novel, mechanistically targeted interventions that extend beyond conventional antidepressant paradigms. Recent advances in neuroscience, endocrinology, and molecular biology have revealed complex biochemical pathways implicated in the onset and progression of PPD, offering promising avenues for next-generation therapies. Dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, altered neuroinflammatory responses, disruptions in neurosteroid signaling, and imbalances in gut–brain axis communication are increasingly recognized as key contributors to postpartum mood disturbances. Innovative therapeutic strategies targeting these pathways, such as the modulation of allopregnanolone and related neurosteroids, anti-inflammatory agents, gut microbiome interventions, and hormonal regulation therapies, have demonstrated potential in preclinical and early clinical studies. Moreover, precision medicine approaches integrating biomarker identification and genetic profiling hold promise for tailoring interventions to individual patient profiles, enhancing treatment efficacy while minimizing adverse effects. This paradigm shift from symptom management to biochemical pathway modulation signals the emergence of a new era in PPD treatment. By harnessing cross-disciplinary insights from psychiatry, immunology, endocrinology, and systems biology, future therapies can more effectively address the multifactorial nature of postpartum depression. Such advancements not only promise improved maternal mental health outcomes but also safeguard child development and strengthen family resilience. Ultimately, exploring these biochemical underpinnings offers a transformative path toward developing safe, rapid, and sustainable next-generation interventions for postpartum depression. Bridging these scientific advances with scalable, real-world clinical applications will be critical to ensuring equitable access and meaningful outcomes for mothers worldwide.

Keywords

Postpartum DepressionBiochemical PathwaysHypothalamic–Pituitary–Adrenal (Hpa) AxisNeurosteroidsAllopregnanoloneNeuroinflammationGut–Brain AxisHormonal RegulationPrecision MedicineNext-Generation Therapies

References

  1. Adeleke O. Conceptual framework for Revenue Cycle Management and Hospital Billing Optimization: Evaluating the Financial Impact of Home Health Agencies in the US Healthcare Ecosystem [Internet]. 2023 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  2. Adeleke O, Ajayi SAO. A model for optimizing Revenue Cycle Management in Healthcare Africa and USA: AI and IT Solutions for Business Process Automation [Internet]. 2023 [cited 2025 Nov 1 [Google Scholar][Crossref]
  3. . Available from: [URL not provided] 3. Adeleke O, Ajayi SAO. Transforming the Healthcare Revenue Cycle with Artificial Intelligence in the USA [Internet]. 2024 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  4. Adeleke O, Olajide O. Conceptual Framework for Health-Care Project Management: Past and Emerging Models [Internet]. 2024 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  5. Adelusi BS, Osamika D, Chinyeaka M, Kelvin-Agwu AYM, Ikhalea N. A Data-Driven Framework for Early Detection and Prevention of Non-Communicable Diseases in Healthcare Systems [Internet]. 2024 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  6. Adelusi BS, Osamika D, Kelvin-Agwu MC, Mustapha AY, Ikhalea N. A deep learning approach to predicting diabetes mellitus using electronic health records. J Front Multidiscip Res. 2022;3(1):47-56. [Google Scholar][Crossref]
  7. Adeshina YT. Leveraging Business Intelligence Dashboards For Real-Time Clinical And Operational Transformation In Healthcare Enterprises [Internet]. 2021 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  8. Adeshina YT. Strategic implementation of predictive analytics and business intelligence for value-based healthcare performance optimization in US health sector [Internet]. 2023 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  9. Adeshina YT, Owolabi BO, Olasupo SO. A US National Framework for Quantum-Enhanced Federated Analytics In Population Health Early-Warning Systems [Internet]. 2023 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  10. Afolabi O, Ajayi S, Olulaja O. Barriers to healthcare among undocumented immigrants. In: 2024 Illinois Minority Health Conference; 2024 Oct 23; Naperville, IL. Springfield (IL): Illinois Department of Public Health; 2024. [Google Scholar][Crossref]
  11. Afolabi O, Ajayi S, Olulaja O. Digital health interventions among ethnic minorities: Barriers and facilitators. Paper presented at: 2024 Illinois Minority Health Conference; 2024 Oct 23; Naperville, IL. [Google Scholar][Crossref]
  12. Ajayi SAO, Akanji OO. Impact of BMI and Menstrual Cycle Phases on Salivary Amylase: A Physiological and Biochemical Perspective [Internet]. 2021 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  13. Ajayi SAO, Akanji OO. Air Quality Monitoring in Nigeria’s Urban Areas: Effectiveness and Challenges in Reducing Public Health Risks [Internet]. 2022 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  14. Ajayi SAO, Akanji OO. Efficacy of Mobile Health Apps in Blood Pressure Control in USA [Internet]. 2022 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  15. Ajayi SAO, Akanji OO. Substance Abuse Treatment through Tele health: Public Health Impacts for Nigeria [Internet]. 2022 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  16. Ajayi SAO, Akanji OO. AI-powered Telehealth Tools: Implications for Public Health in Nigeria [Internet]. 2023 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  17. Ajayi SAO, Akanji OO. Impact of AI -Driven Electrocardiogram Interpretation in Reducing Diagnostic Delays [Internet]. 2023 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  18. Ajayi SA-O, Onyeka MU-E, Jean-Marie AE, Olayemi OA, Oluwaleke A, Frank NO, et al. Strengthening primary care infrastructure to expand access to preventative public health services. World J Adv Res Rev. 2024;26(1). [Google Scholar][Crossref]
  19. Akanji OO, Ajayi SA-O. Efficacy of mobile health apps in blood pressure control. Int J Multidiscip Res Growth Eval. 2022;3(5):635 -40. doi:10.54660/.IJMRGE.2022.3.5.635-640 [Google Scholar][Crossref]
  20. Akpan UU, Adekoya KO, Awe ET, Garba N, Oguncoker International Journal of Medical and All Body Health Research www.allmedicaljournal.com GD, Ojo SG. Mini-STRs screening of 12 relatives of Hausa origin in northern Nigeria. Niger J Basic Appl Sci. 2017;25(1):48-57. [Google Scholar][Crossref]
  21. Akpan UU, Awe TE, Idowu D. Types and frequency of fingerprint minutiae in individuals of Igbo and Yoruba ethnic groups of Nigeria. Ruhuna J Sci. 2019;10(1). [Google Scholar][Crossref]
  22. Alanazi AF. Maternal Mental Health: Understanding and Addressing Postpartum Depression [Internet]. 2019 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  23. Alanezi AF, Ibrahim AH, Ibrahim NH, Ibrahim EH, Alqousi HM, Alonazi MF, et al. Postpartum Depression: Endocrine Factors, Biochemical Markers, and the Role of Nursing Interventions. J Int Crisis Risk Commun Res. 2024;7(S10):283. [Google Scholar][Crossref]
  24. Alexander L, Young AH. Recent advances in the psychopharmacology of major depressive disorder. BJPsych Adv. 2023;29(2):117 -30. doi:10.1192/bja.2022.43 [Google Scholar][Crossref]
  25. Amer SA, Zaitoun NA, Abdelsalam HA, Abbas A, Ramadan MS, Ayal HM, et al. Exploring predictors and prevalence of postpartum depression among mothers: Multinational study. BMC Public Health. 2024;24(1):1308. doi:10.1186/s12889-024-18674-8 [Google Scholar][Crossref]
  26. Awe ET. Hybridization of snout mouth deformed and normal mouth African catfish Clarias gariepinus. Anim Res Int. 2017;14(3):2804-8. [Google Scholar][Crossref]
  27. Awe ET, Akpan UU. Cytological study of Allium cepa and Allium sativum [Internet]. 2017 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  28. Awe ET, Akpan UU, Adekoya KO. Evaluation of two MiniSTR loci mutation events in five Father-Mother-Child trios of Yoruba origin. Niger J Biotechnol. 2017;33:120-4. [Google Scholar][Crossref]
  29. Awe T. Cellular Localization Of Iron-Handling Proteins Required For Magnetic Orientation In C. Elegans [Internet]. 2021 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  30. Awe T, Akinosho A, Niha S, Kelly L, Adams J, Stein W, et al. The AMsh glia of C. elegans modulates the duration of touch-induced escape responses. bioRxiv. 2023:2023-12. doi:10.1101/2023.12.XX.XXXXXX [Google Scholar][Crossref]
  31. Awe T, Fasawe A, Sawe C, Ogunware A, Jamiu AT, Allen M. The modulatory role of gut microbiota on host behavior: exploring the interaction between the brain-gut axis and the neuroendocrine system. AIMS Neurosci. 2024;11(1):49. doi:10.3934/Neuroscience.202400X [Google Scholar][Crossref]
  32. Bener A, Burgut FT, Ghuloum S, Sheikh J. A study of postpartum depression in a fast developing country: prevalence and related factors. Int J Psychiatry Med. 2012;43(4):325-37. doi:10.2190/PM.43.4.c [Google Scholar][Crossref]
  33. Bener A, Gerber LM, Sheikh J. Prevalence of psychiatric disorders and associated risk factors in women during their postpartum period: a major public health problem and global comparison. Int J Womens Health. 2012;4:191-200. doi:10.2147/IJWH.S29380 [Google Scholar][Crossref]
  34. Bhagar R, Gill SS, Le-Niculescu H, Yin C, Roseberry K, Mullen J, et al. Next-generation precision medicine for suicidality prevention. Transl Psychiatry. 2024;14(1):362. doi:10.1038/s41398-024-03056-5 [Google Scholar][Crossref]
  35. Cai M, Wang H, Zhang X. Potential anti-depressive treatment maneuvers from bench to bedside. In: Depressive disorders: Mechanisms, measurement and management. Singapore: Springer; 2019. p. 277-95. [Google Scholar][Crossref]
  36. Carlini SV, Osborne LM, Deligiannidis KM. Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression. Dialogues Clin Neurosci. 2023;25(1):92-100. doi:10.1080/19585969.2023.2271272 [Google Scholar][Crossref]
  37. Cowan CS, Callaghan BL, Kan JM, Richardson R. The lasting impact of early‐life adversity on individuals and their descendants: Potential mechanisms and hope for intervention. Genes Brain Behav. 2016;15(1):155-68. doi:10.1111/gbb.12263 [Google Scholar][Crossref]
  38. Dennis CL, Singla DR, Brown HK, Savel K, Clark CT, Grigoriadis S, et al. Postpartum depression: A clinical review of impact and current treatment solutions. Drugs. 2024;84(6):645-59. doi:10.1007/s40265-024-02035-5 [Google Scholar][Crossref]
  39. Douthard R, Whitten LA, Clayton JA. Research on women's health: Ready for the future. J Womens Health (Larchmt). 2022;31(2):133 -44. doi:10.1089/jwh.2021.0574 [Google Scholar][Crossref]
  40. Dunkel Schetter C, Saxbe DE, Cheadle AC, Guardino CM. Postpartum depressive symptoms following consecutive pregnancies: Stability, change, and mechanisms. Clin Psychol Sci. 2016;4(5):909-18. doi:10.1177/2167702616640923 [Google Scholar][Crossref]
  41. Duskin CU. Experiences of social comparison in a postpartum depression support group [dissertation]. San Francisco (CA): California Institute of Integral Studies; 2005. [Google Scholar][Crossref]
  42. Exclusivity B. 31st Annual Scientific Sessions: Transforming the Future of Nursing Research: Imagination, Innovation and Engagement. Nurs Res. 2019;68(2):E21. [Google Scholar][Crossref]
  43. Gilbert LR, Nguyen JL, Scroggins MJ. Women’s Health Equity. In: Health Equity: A Solutions-Focused Approach. New York: Springer Publishing Company; 2021. p. 177-96. [Google Scholar][Crossref]
  44. Glover ME, Clinton SM. Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research. Int J Dev Neurosci. 2016;51:50-72. doi:10.1016/j.ijdevneu.2016.04.008 [Google Scholar][Crossref]
  45. Gold PW. Breaking Through Depression: A Guide to the Next Generation of Promising Research and Revolutionary New Treatments. New York: Twelve; 2023. [Google Scholar][Crossref]
  46. Groth SW, Fernandez ID, Block RC, Thurston SW, Wong E, Brunner J, et al. Biological changes in the pregnancy‐postpartum period and subsequent cardiometabolic risk UPSIDE MOMS: A research protocol. Res Nurs Health. 2021;44(4):608-19. doi:10.1002/nur.22146 [Google Scholar][Crossref]
  47. Gupta A, Pajai S, Gupta A, Thakur AS, Muneeba S, Batra N, et al. In the shadows of motherhood: a comprehensive review of postpartum depression screening and intervention practices. Cureus. 2024;16(2):eXXXXX. doi:10.7759/cureus.XXXXX [Google Scholar][Crossref]
  48. Gururajan A, Reif A, Cryan JF, Slattery DA. The future of rodent models in depression research. Nat Rev Neurosci. 2019;20(11):686-701. doi:10.1038/s41583-019-0221-6 [Google Scholar][Crossref]
  49. Hahn-Holbrook J, Cornwell-Hinrichs T, Anaya I. Economic and health predictors of national postpartum depression prevalence: a systematic review, meta-analysis, and meta-regression of 291 studies from 56 countries. Front Psychiatry. 2018;8:248. doi:10.3389/fpsyt.2017.00248 International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
  50. Halliday NN. Assessment of Major Air Pollutants, Impact on Air Quality and Health Impacts on Residents: Case Study of Cardiovascular Diseases [master's thesis]. Cincinnati (OH): University of Cincinnati; 2021. [Google Scholar][Crossref]
  51. Ilori O, Kolawole TO, Olaboye JA. Ethical dilemmas in healthcare management: A comprehensive review. Int Med Sci Res J. 2024;4(6):703-25. [Google Scholar][Crossref]
  52. Imohiosen CE, Tomoh BO, Soyege OS, Nwokedi CN, Mustapha AY, Mbata AO, et al. Leadership in healthcare: Building high-performing teams and cultivating a culture of continuous improvement. J Front Multidiscip Res. 2024;5(2):36-41. [Google Scholar][Crossref]
  53. Imohiosen C, Olinmah FI, Adams OA, Otokiti BO, Abutu DE, Okoli I. Constructing organizational engagement dashboards for strategic communication in academic institutions. Int J Adv Multidiscip Res Stud. 2023;3(6):1803-10. [Google Scholar][Crossref]
  54. Imohiosen C, Otokiti BO, Olinmah FI, Adams OA, Abutu DE, Okoli I. Designing interactive visual analysis frameworks for higher education: Feedback and satisfaction insights. Int J Soc Sci Except Res. 2022;1(2):156-63. [Google Scholar][Crossref]
  55. Isa AK. Occupational hazards in the healthcare system. Paper presented at: Gwarinpa General Hospital; 2022 Apr 27; Abuja, Nigeria. [Google Scholar][Crossref]
  56. Isa AK. Management of bipolar disorder. Paper presented at: Maitama District Hospital; 2022 Mar 17; Abuja, Nigeria. [Google Scholar][Crossref]
  57. Isa AK. Exploring digital therapeutics for mental health: Ai-driven innovations in personalized treatment approaches. World J Adv Res Rev. 2024;24(3):10-30574. [Google Scholar][Crossref]
  58. Isa AK. Strengthening connections: Integrating mental health and disability support for urban populations. Paper presented at: Illinois Public Health Association 83rd Annual Conference; 2024 Nov 19; Springfield, IL. [Google Scholar][Crossref]
  59. Isa AK. Empowering minds: The impact of community and faith-based organizations on mental health in minority communities: Systematic review. Paper presented at: Illinois Minority Health Conference; 2024 Oct 23; Naperville, IL. [Google Scholar][Crossref]
  60. Isa AK. IDPH public health career presentation showcase (for junior high/high school students in Illinois). Presentation delivered at: UIS Center for State Policy and Leadership Showcase; 2024 Sep 25; Springfield, IL. [Google Scholar][Crossref]
  61. Isa AK, Johnbull OA, Ovenseri AC. Evaluation of Citrus sinensis (orange) peel pectin as a binding agent in erythromycin tablet formulation. World J Pharm Pharm Sci. 2021;10(10):188-202. [Google Scholar][Crossref]
  62. Isa A, Dem B. Integrating Self-Reliance Education Curriculum For Purdah Women In Northern Nigeria: A Panacea For A Lasting Culture Of Peace [Internet]. 2014 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  63. Jelen LA, Young AH. New antidepressants: New day or false dawn. Eur Neuropsychopharmacol. 2022;63:1-3. doi:10.1016/j.euroneuro.2022.08.001 [Google Scholar][Crossref]
  64. Kaustinen K. Building a new toolbox [Internet]. 2019 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  65. Kraus C, Kadriu B, Lanzenberger R, Zarate CA Jr, Kasper S. Prognosis and improved outcomes in major depression: a review. Transl Psychiatry. 2019;9(1):127. doi:10.1038/s41398-019-0460-4 [Google Scholar][Crossref]
  66. Kraus C, Wasserman D, Henter ID, Acevedo-Diaz E, Kadriu B, Zarate CA Jr. The influence of ketamine on drug discovery in depression. Drug Discov Today. 2019;24(10):2033-43. doi:10.1016/j.drudis.2019.07.007 [Google Scholar][Crossref]
  67. LeGates TA, Kvarta MD, Thompson SM. Sex differences in antidepressant efficacy. Neuropsychopharmacology. 2019;44(1):140-54. doi:10.1038/s41386-018-0185-9 [Google Scholar][Crossref]
  68. Lehman BJ, David DM, Gruber JA. Rethinking the biopsychosocial model of health: Understanding health as a dynamic system. Soc Personal Psychol Compass. 2017;11(8):e12328. doi:10.1111/spc3.12328 [Google Scholar][Crossref]
  69. Liu L, Wang H, Chen X, Zhang Y, Zhang H, Xie P. Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. 2023;90:104527. doi:10.1016/j.ebiom.2023.104527 [Google Scholar][Crossref]
  70. Liu X, Wang S, Wang G. Prevalence and risk factors of postpartum depression in women: A systematic review and meta‐analysis. J Clin Nurs. 2022;31(19-20):2665-77. doi:10.1111/jocn.16121 [Google Scholar][Crossref]
  71. Liu Y, Zhang L, Guo N, Jiang H. Postpartum depression and postpartum post-traumatic stress disorder: prevalence and associated factors. BMC Psychiatry. 2021;21(1):487. doi:10.1186/s12888-021-03432-7 [Google Scholar][Crossref]
  72. Lüscher B, Möhler H. Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience. F1000Res. 2019;8:F1000 Facul ty Rev-751. doi:10.12688/f1000research.18758.1 [Google Scholar][Crossref]
  73. Modak A, Ronghe V, Gomase KP, Mahakalkar MG, Taksande V, Dukare KP. A comprehensive review of motherhood and mental health: postpartum mood disorders in focus. Cureus. 2023;15(9):eXXXXX. doi:10.7759/cureus.XXXXX [Google Scholar][Crossref]
  74. Mughal S, Azhar Y, Siddiqui W. Postpartum depression [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 [updated 2023 Oct 7; cited 2025 Nov 1 3] . Available from: https://www.ncbi.nlm.nih.gov/books/NBK519070/ [Google Scholar][Crossref]
  75. Nsa B, Anyebe V, Dimkpa C, Aboki D, Egbule D, Useni S, et al. Impact of active case finding of tuberculosis among prisoners using the WOW truck in North Central Nigeria. Int J Tuberc Lung Dis. 2018;22(11):S444. [Google Scholar][Crossref]
  76. Oboh A, Uwaifo F, Gabriel OJ, Uwaifo AO, Ajayi SAO, Ukoba JU. Multi-Organ toxicity of organophosphate compounds: hepatotoxic, nephrotoxic, and cardiotoxic effects. Int Med Sci Res J. 2024;4(8):797-805. [Google Scholar][Crossref]
  77. Oh G, Wang SC, Pal M, Chen ZF, Khare T, Tochigi M, et al. DNA modification study of major depressive disorder: beyond locus-by-locus comparisons. Biol Psychiatry. 2015;77(3):246 -55. doi:10.1016/j.biopsych.2014.06.016 [Google Scholar][Crossref]
  78. Ojika FU, Onaghinor O, Esan OJ, Daraojimba AI, Ubamadu BC. Designing a business analytics model for optimizing healthcare supply chains during epidemic outbreaks: Enhancing efficiency and strategic resource allocation. Int J Multidiscip Res Growth Eval. 2024;5(1):1657-67. [Google Scholar][Crossref]
  79. Okolie CI, Hamza O, Eweje A, Collins A, Babatunde GO, Ubamadu BC. Leveraging Digital Transformation and Business Analysis to Improve Healthcare Provider Portal. Iconic Res Eng J. 2021;4(10):253-7. [Google Scholar][Crossref]
  80. Olajide JO, Otokiti BO, Nwani S, Ogunmokun AS, Adekunle BI, Fiemotongha JE. A Framework for Gross Margin Expansion Through Factory-Specific Financial International Journal of Medical and All Body Health Research www.allmedicaljournal.com Health Checks. IRE J. 2021;5(5):487-9. [Google Scholar][Crossref]
  81. Olsen J, Nøhr EA, Thomsen RW, Støvring H. Non-communicable disease epidemic: Epidemiology in action (EuroEpi 2013 and NordicEpi 2013). Methods. 2013;12:1-8. [Google Scholar][Crossref]
  82. Olulaja O, Afolabi O, Ajayi S. Bridging gaps in preventive healthcare: Telehealth and digital innovations for rural communities. Paper presented at: 2024 Illinois Minority Health Conference; 2024 Oct 23; Naperville, IL. Springfield (IL): Illinois Department of Public Health; 2024. [Google Scholar][Crossref]
  83. Oluwadamilola A, Simeon A-O A. Transforming the healthcare revenue cycle with artificial intelligence in the USA. Int J Multidiscip Res Growth Eval. 2024;5(6):1670-84. [Google Scholar][Crossref]
  84. Onuoha O. A Staff Education Module for Depression Screening in Acute Care [doctoral dissertation]. Minneapolis (MN): Walden University; 2019. [Google Scholar][Crossref]
  85. Owot JA, Imohiosen CE, Ukpo SD, Ajuluchukwu P. Tailored Spiritual Support for the Aging Population: Developing a Model for Religious Counseling in Long-Term Care Facilities [Internet]. 2024 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  86. Palmer E. A Qualitative Study of Existential Issues in Postpartum Depression: An Unspoken Truth [dissertation]. Colorado Springs (CO): University of the Rockies; 2011. [Google Scholar][Crossref]
  87. Postolache TT, del Bosque-Plata L, Jabbour S, Vergare M, Wu R, Gragnoli C. Co‐shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome. Am J Med Genet B Neuropsychiatr Genet. 2019;180(3):186-203. doi:10.1002/ajmg.b.32721 [Google Scholar][Crossref]
  88. Ramsteijn AS, Jašarević E, Houwing DJ, Bale TL, Olivier JD. Antidepressant treatment modulates the gut microbiome and metabolome during pregnancy and lactation in rats with a depressive-like phenotype. bioRxiv. 2018:501742. doi:10.1101/501742 [Google Scholar][Crossref]
  89. Saharoy R, Potdukhe A, Wanjari M, Taksande AB. Postpartum depression and maternal care: exploring the complex effects on mothers and infants. Cureus. 2023;15(7):eXXXXX. doi:10.7759/cureus.XXXXX [Google Scholar][Crossref]
  90. Scholten J, Eneogu R, Ogbudebe C, Nsa B, Anozie I, Anyebe V, et al. Ending the TB epidemic: role of active TB case finding using mobile units for early diagnosis of tuberculosis in Nigeria. Int Union Against Tuberc Lung Dis. 2018;11:22. [Google Scholar][Crossref]
  91. Snair M; National Academies of Sciences, Engineering, and Medicine. Overview of Research Gaps for Selected Conditions in Women’s Health Research at the National Institutes of Health. Washington (DC): National Academies Press; 2024. [Google Scholar][Crossref]
  92. Soyege OS, Nwokedi CN, Tomoh BO, Mustapha AY, Mbata AO, Balogun OD, et al. Public Health Crisis Management and Emergency Preparedness: Strengthening Healthcare Infrastructure Against Pandemics and Bioterrorism Threats. J Front Multidiscip Res. 2024;5(2):52 -68. doi:10.54660/.IJFMR.2024.5.2.52-68 [Google Scholar][Crossref]
  93. Stana A, Miller AR. “Being a mom= having all the feels”: social support in a postpartum depression online support group. Atl J Commun. 2019;27(5):297-310. doi:10.1080/15456870.2019.1610922 [Google Scholar][Crossref]
  94. Starrs AM, Ezeh AC, Barker G, Basu A, Bertrand JT, Blum R, et al. Accelerate progress sexual and reproductive health and rights for all: report of the Guttmacher–Lancet Commission. Lancet. 2018;391(10140):2642-92. doi:10.1016/S0140 -6736(18)30293-9 [Google Scholar][Crossref]
  95. Thurgood S, Avery DM, Williamson L. Postpartum depression (PPD). Am J Clin Med. 2009;6(2):17-22. [Google Scholar][Crossref]
  96. Tolossa T, Fetensa G, Yilma MT, Abadiga M, Wakuma B, Besho M, et al. Postpartum depression and associated factors among postpartum women in Ethiopia: a systematic review and meta-analysis, 2020. Public Health Rev. 2020;41(1):21. doi:10.1186/s40985-020-00136-8 [Google Scholar][Crossref]
  97. Tomoh BO, Soyege OS, Nwokedi CN, Mustapha AY, Mbata AO, Balogun OD, et al. Leadership in Healthcare: Building High-Performing Teams and Cultivating a Culture of Continuous Improvement [Internet]. 2024 [cited 2025 Nov 1 3] . Available from: [URL not provided] [Google Scholar][Crossref]
  98. Ukpo SD, Imohiosen CE, Owot JA, Ajuluchukwu P. The impact of religious and spiritual counseling on mental health outcomes in geriatric care. Int J Multidiscip Res Growth Eval. 2024;5(6):1538-47. [Google Scholar][Crossref]
  99. Wang Z, Liu J, Shuai H, Cai Z, Fu X, Liu Y, et al. Mapping global prevalence of depression among postpartum women. Transl Psychiatry. 2021;11(1):543. doi:10.1038/s41398-021-01663-6 [Google Scholar][Crossref]
  100. Williams DR, Mohammed SA, Shields AE. Understanding and effectively addressing breast cancer in African American women: Unpacking the social context. Cancer. 2016;122(14):2138 -49. doi:10.1002/cncr.29935 [Google Scholar][Crossref]
  101. Yim IS, Glynn LM, Schetter CD, Hobel CJ, Chicz-DeMet A, Sandman CA. Risk of postpartum depressive symptoms with elevated corticotropin-releasing hormone in human pregnancy. Arch Gen Psychiatry. 2009;66(2):162-9. doi:10.1001/archgenpsychiatry.2008.533 [Google Scholar][Crossref]
  102. Yim IS, Tanner Stapleton LR, Guardino CM, Hahn-Holbrook J, Dunkel Schetter C. Biological and psychosocial predictors of postpartum depression: systematic review and call for integration. Annu Rev Clin Psychol. 2015;11(1):99-137. doi:10.1146/annurev-clinpsy-101414-020426 [Google Scholar][Crossref]
  103. Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature. 2016;533(7604):481-6. doi:10.1038/nature17998 [Google Scholar][Crossref]

How to Cite

Owokoya, A. O. (2025). Beyond Antidepressants: Exploring Biochemical Pathways for Next-Generation Postpartum Depression Therapies. International Journal of Medical and All Body Health Research, 6(4), 77-92. https://doi.org/10.54660/IJMBHR.2025.6.4.77-92

Owokoya, Abidemi Omolayo. "Beyond Antidepressants: Exploring Biochemical Pathways for Next-Generation Postpartum Depression Therapies." International Journal of Medical and All Body Health Research, vol. 6, no. 4, 2025, pp. 77-92. https://doi.org/10.54660/IJMBHR.2025.6.4.77-92.

Owokoya, A. O. (2025) 'Beyond Antidepressants: Exploring Biochemical Pathways for Next-Generation Postpartum Depression Therapies', International Journal of Medical and All Body Health Research, 6(4), pp. 77-92. doi: 10.54660/IJMBHR.2025.6.4.77-92.

Owokoya AO. Beyond Antidepressants: Exploring Biochemical Pathways for Next-Generation Postpartum Depression Therapies. International Journal of Medical and All Body Health Research. 2025;6(4):77-92. doi:10.54660/IJMBHR.2025.6.4.77-92

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.